InvestorsHub Logo
Followers 28
Posts 4378
Boards Moderated 1
Alias Born 09/22/2006

Re: biotechinvestor1 post# 7020

Monday, 03/28/2022 4:09:47 PM

Monday, March 28, 2022 4:09:47 PM

Post# of 8735
Good find, thanks. BMY already has Opdivo-Enhanze combo in Phase 3 trials for renal cell carcinoma. I'd imagine that will be a fairly near term catalyst assuming good results.

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News